PNV 0.38% $2.64 polynovo limited

Ann: Update - SynPath Diabetic Foot Ulcer Trial, page-10

  1. 376 Posts.
    lightbulb Created with Sketch. 109
    I'm with Hookey, it would make sense that they would prefer a result re positive outcomes sooner rather than later, and given that they are 16 weeks from anticipated end date for recruitment and are 113 patients short, they may amend the numbers and/or date. Having said that, the statistcal power of the study will be reduced with a reduction in numbers though....we wait in anticipation
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.